Three-dimensional structure of the tn5 synaptic complex transposition intermediate

Science

Volumn 289, Issue 5476, 2000, Pages 77-85

  Davies, Douglas R ^a   Goryshin, Igor Y ^a   Reznikoff, William S ^a   Rayment, Ivan ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE; TRANSPOSASE;

ARTICLE; DNA DETERMINATION; DNA PROTEIN COMPLEX; DNA TRANSPOSITION; ENZYME ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS; TRANSPOSON;

AMINO ACID MOTIFS; BINDING SITES; CATALYSIS; CATALYTIC DOMAIN; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; DNA; DNA TRANSPOSABLE ELEMENTS; MANGANESE; MUTATION; NUCLEIC ACID CONFORMATION; PLASMIDS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; TRANSPOSASES;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; PROKARYOTA;

EID: 0034616993     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.289.5476.77     Document Type: Article

References (67)

1. B. McClintock, Cold Spring Harbor Symp. Quant. Biol. 16, 13 (1951).
2. K. Mizuuchi, Annu. Rev. Biochem. 61, 1011 (1992).
3. _, Genes Cells 2, 1 (1997).
4. N. L. Craig, Science 270, 253 (1995).
5. C. Bujacz et al., J. Mol. Biol. 253, 333 (1995).
6. D. R. Davies, L. M. Braam, W. S. Reznikoff, I. Rayment, J. Biol. Chem. 274, 11904 (1999).
7. Z. N. Yang, T. C. Mueser, F. D. Bushman, C. C. Hyde, J. Mol. Biol. 296, 535 (2000).
8. W. S. Reznikoff et al., Biochem. Biophys. Res. Commun. 266, 729 (1999).
9. A. K. Kennedy, A. Guhathakurta, N. Kleckner, D. B. Haniford, Cell 95, 125 (1998).
10. A. Bhasin, I. Y. Goryshin, W. S. Reznikoff, J. Biol. Chem. 274, 37021 (1999).
11. M. A. Landree, J. A. Wibbenmeyer, D. B. Roth, Genes Dev. 13, 3059 (1999).
12. D. R. Kim, Y. Dai, C. L. Mundy, W. Yang, M. A. Oettinger, Genes Dev. 13, 3070 (1999).
13. S. D. Fugmann, I. J. Villey, L. M. Ptaszek, D. G. Schatz, Mot. Cell 5, 97 (2000).
14. J. F. McBlane et al., Cell 83, 387 (1995).
15. A. Agrawal, Q. M. Eastman, D. G. Schatz, Nature 394, 744 (1998).
16. D. C. van Gent, K. Mizuuchi, M. Gellert, Science 271, 1592 (1996).
17. P. Rice and K. Mizuuchi, Cell 82, 209 (1995).
18. F. Dyda et al., Science 266, 1981 (1994).
19. M. Cai et al., Nature Struct. Biol. 4, 567 (1997).
20. A. P. Eijkelenboom et al., Proteins 36, 556 (1999).
21. S. Schumacher et al., EMBO J. 16, 7532 (1997).
22. G. van Pouderoyen, R. F. Ketting, A. Perrakis, R. H. Plasterk, T. K. Sixma, EMBO J. 16, 6044 (1997).
23. I. Y. Goryshin and W. S. Reznikoff, J. Biol. Chem. 273, 7367 (1998).
24. S. R. Jordan, T. V. Whitcombe, J. M. Berg, C. O. Pabo, Science 230, 1383 (1985).
25. 2 to crystals improved the diffraction limit of native crystals on a laboratory rotating anode x-ray source from ∼3.4 Å to better than 2.9 Å.
26. Selenomethionine-labeled protein was prepared by growing the expression strain of Escherichia coli in liquid minimal media with selenomethionine replacing methionine. Labeled protein was purified and crystallized in the same manner as the native transposase, except for the inclusion of 2 mM tris (2-carboxyethyl)-phosphine hydrochloride. A ter(pyridine)PtCl derivative containing two heavy atom sites was produced by soaking crystals in a 0.5 mM solution for 12 hours, and a uranyl acetate derivative containing three heavy-atom sites was produced from a 36-hour soak at 5 mM. Diffraction data were collected at the Structural Biology Center beamline at the Advanced Photon Source in Argonne, IL (Table 1). Data were integrated, scanned and reduced with the HKL software (58). Phases from multiple isomorphous replacement were calculated and improved by density modification using CN5, version 0.5 (59). The model was built into the resulting electron density map with the program TURBO-FRODO (60). Thereafter, the model was improved through cycles of manual model building and refinement by simulated annealing with cross-validated maximum likelihood (61, 62) with CN5, version 1.0.
27. A. G. Murzin, S. E. Brenner, T. Hubbard, C. Chothia, J. Mol. Biol. 247, 536 (1995).
28. I. Y. Goryshin, data not shown.
29. A. Bhasin, I. Y. Goryshin, W. S. Reznikoff, J. Mol. Biol., in press.
30. M. D. Weinreich, L. Mahnke-Braam, W. S. Reznikoff J. Mol. Biol. 241, 166 (1993).
31. M. Zhou and W. S. Reznikoff, J. Mol. Biol. 271, 362 (1997).
32. T. A. Naumann and W. S. Reznikoff, Proc. Natl. Acad. Sci. U.S.A., in press.
33. T. A. Baker, M. Mizuuchi, H. Savilahti, K. Mizuuchi, Cell 74, 723 (1993).
34. D. C. van Gent, C. Vink, A. A. Groeneger, R. H. Plasterk, EMBO J. 12, 3261 (1993).
35. V. Ellison, J. Gerton, K. A. Vincent, P. O. Brown, J. Biol. Chem. 270, 3320 (1995).
36. R. Lavery and H. Sklenar J. Biomol. Struct. Dyn. 6, 655 (1989).
37. E. Stofer and R. Lavery, Biopolymers 34, 337 (1994).
38. D. York and W. S. Reznikoff, Nucleic Acids Res. 25, 2153 (1997).
39. R. A. Jilk, D. York, W. S. Reznikoff, J. Bacteriol. 178, 1671 (1996).
40. W. F. Anderson, Y. Takeda, H. Echols, B. W. Matthews, J. Mol. Biol. 130, 507 (1979).
41. M. Tateno et al., Biopolymers 44, 335 (1997).
42. S. Bolland and N. Kleckner, Cell 84, 223 (1996).
43. T. Naumann and W. S. Reznikoff, in preparation.
44. J. S. Allingham, P. A. Pribil, D. B. Haniford, J. Mol. Biol. 289, 1195 (1999).
45. G. Bujacz et al. Structure 14, 89 (1996).
46. Y. Goldgur et al., Proc. Natl. Acad. Sci. U.S.A. 95, 9150 (1998).
47. G. Bujacz et al., J. Biol. Chem. 272, 18161 (1997).
48. T. A. Steitz, S. J. Smerdon, J. Jager, C. M. Joyce, Science 266, 2022 (1994).
49. R. J. Roberts and X. Cheng, Annu. Rev. Biochem. 67, 181 (1998).
50. R. Rezsohazy, B. Hallet, J. Delcour, J. Mahillon, Mol. Microbiol. 9, 1283 (1993).
51. T. M. Jenkins, D. Esposito, A. Engelman, R. Craigie, EMBO J. 16, 6849 (1997).
52. D. J. Hazuda et al., Science 287, 646 (2000).
53. L. M. Braam, I. Y. Goryshin, W. S. Reznikoff, J. Biol. Chem. 274, 86 (1999).
54. M. Steiniger-White and W. S. Reznikoff, J. Biol. Chem., in press.
55. T. W. Wiegand and W. S. Reznikoff, J. Bacteriol. 174, 1229 (1992).
56. D. York and W. S. Reznikoff, Nucleic Acids Res. 24, 3790 (1996).
57. R. R. Isberg and M. Syvanen, J. Biol. Chem. 260, 3645 (1985).
58. Z. Otwinowski and W. Minor, Methods Enzymol. 276, 307 (1997).
59. A. T. Brunger et al., Acta Crystallogr. D 54, 905 (1998).
60. A. Roussel and C. Cambitau, in Silicon Graphics Geometry Partners Directory (Silicon Graphics, Mountain View, CA, 1991), vol. 86.
61. N. S. Pannu and R. J. Read, Acta Crystallogr. A 52, 659 (1996).
62. P. D. Adams, N. S. Pannu, R. J. Read, A. T. Brünger, Proc. Natl. Acad. Sci. U.S.A. 94, 5018 (1997).
63. M. Carson, Methods Enzymol. 277, 493 (1997).
64. R. J. Read, Acta Crystallogr. A 42, 140 (1986).
65. C. H. Cohen, J. Mol. Biol. 190, 593 (1986).
66. _, J. Appl. Crystallogr. 30, 1160 (1997).
67. We thank L. Mahnke for providing the first samples of purified transposase, J. B. Thoden for help in collecting the x-ray data, and T. Naumann, A. Bhasin, M. Steiniger-White and R. Saecker for helpful discussions. We gratefully acknowledge the help of N. Duke, F. Rotella, and A. Joachimak at the Structural Biology Center Beamline, Argonne National Laboratory, in collecting the data. This research was supported in part by NIH grants AR35186 (I.R.) and CM50692 (W.S.R.). W.S.R. is a recipient of a Vilas Associates Award and is the Evelyn Mercer Professor of Biochemistry and Molecular Biology. D.R.D. was supported by the NIH Biotechnology Training Grant. The use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Energy Research, Contract W-31-109-Eng-38. The PDB accession number for the coordinates and structure factors is 1F3I for the transposase/DNA complex.